Citation Impact
Citing Papers
H 2 S as a Physiologic Vasorelaxant: Hypertension in Mice with Deletion of Cystathionine γ-Lyase
2008 StandoutScience
The endocannabinoid nervous system
2001
Endothelial-Derived Hyperpolarization Factor (EDHF) Contributes to PlGF-Induced Dilation of Mesenteric Resistance Arteries from Pregnant Rats
2011
Cannabinoids promote embryonic and adult hippocampus neurogenesis and produce anxiolytic- and antidepressant-like effects
2005
Cannabinoid pharmacology in the cardiovascular system: potential protective mechanisms through lipid signalling
2004
Arachidonylethanolamide Induces Apoptosis of Human Glioma Cells through Vanilloid Receptor-1
2004
International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors
2002 Standout
Role of endocannabinoids in the pathogenesis of cirrhotic cardiomyopathy in bile duct‐ligated rats
2005
Receptor-independent actions of cannabinoids on cell membranes: Focus on endocannabinoids
2006
Hemodynamic effects of cannabinoids: coronary and cerebral vasodilation mediated by cannabinoid CB1 receptors
2001
Anandamide elicits an acute release of nitric oxide through endothelial TRPV1 receptor activation in the rat arterial mesenteric bed
2005
Endothelium‐dependent vasodilator effects of platelet activating factor on rat resistance vessels
1989
Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action
1998
Circulating endogenous cannabinoid anandamide and portal, systemic and renal hemodynamics in cirrhosis
2004
Cytochrome P450 epoxygenases as EDHF synthase(s)
2004
Potentiation of anandamide hypotension by the transport inhibitor, AM404
1997
Pharmacological Actions of Cannabinoids
2005
Mechanisms and Functional Implications of Adult Neurogenesis
2008 Standout
Presynaptic cannabinoid CB1 receptors are involved in the inhibition of the neurogenic vasopressor response during septic shock in pithed rats
2004
The synthetic cannabinoid WIN55212‐2 decreases the intraocular pressure in human glaucoma resistant to conventional therapies
2001
Endocannabinoids Mediate Presynaptic Inhibition of Glutamatergic Transmission in Rat Ventral Tegmental Area Dopamine Neurons through Activation of CB1 Receptors
2004
Endothelial-dependent vasodilation is reduced in mesenteric arteries from superoxide dismutase knockout mice
2003
Adverse Health Effects of Marijuana Use
2014 Standout
Anandamide Uptake by Human Endothelial Cells and Its Regulation by Nitric Oxide
2000
Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation
1999 StandoutNature
Transient Receptor Potential Channels in Endothelium: Solving the Calcium Entry Puzzle?
2003
The actions of some cannabinoid receptor ligands in the rat isolated mesenteric artery
1998
Endocannabinoid-Mediated Long-Term Plasticity Requires cAMP/PKA Signaling and RIM1α
2007 StandoutNobel
Endocannabinoids protect the rat isolated heart against ischaemia
2003
Endogenous cannabinoids: A new system involved in the homeostasis of arterial pressure in experimental cirrhosis in the rat
2002
Cannabinoids in bipolar affective disorder: a review and discussion of their therapeutic potential
2005
Highly Selective CB1 Cannabinoid Receptor Ligands and Novel CB1/VR1 Vanilloid Receptor “Hybrid” Ligands
2001
Control of pain initiation by endogenous cannabinoids
1998 StandoutNature
Changes in cannabinoid CB1 receptors in striatal and cortical regions of rats with experimental allergic encephalomyelitis, an animal model of multiple sclerosis
2001
Cardiovascular Pharmacology of Cannabinoids
2005
Human brain endothelium: coexpression and function of vanilloid and endocannabinoid receptors
2004
Endocannabinoids
1998
Estrogen receptor α is a major mediator of 17β-estradiol’s atheroprotective effects on lesion size in Apoe–/– mice
2001 StandoutNobel
Contribution of endocannabinoids in the endothelial protection afforded by ischemic preconditioning in the isolated rat heart
2003
Evidence for multiple endothelin receptors in the guinea‐pig pulmonary artery and trachea
1992
Anandamide and vanilloid TRPV1 receptors
2003
Interaction of endothelin-3 with endothelin-B receptor is essential for development of epidermal melanocytes and enteric neurons
1994 Standout
The Protective Effects of Estrogen on the Cardiovascular System
1999 Standout
Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide
1999 StandoutNatureNobel
The Human Intestinal Microbiome in Health and Disease
2016 Standout
Cannabinoids as therapeutic agents in cardiovascular disease: a tale of passions and illusions
2007
Coronary Vasodilator Effects of Endogenous Cannabinoids in Vasopressin-Preconstricted Unpaced Rat Isolated Hearts
2005
Inverse agonism and neutral antagonism at cannabinoid CB1 receptors
2004
New insights into nNOS regulation of vascular homeostasis
2005 StandoutNobel
Natural product agonists of peroxisome proliferator-activated receptor gamma (PPARγ): a review
2014 Standout
Blood pressure regulation by endocannabinoids and their receptors
2005
Evidence that anandamide and EDHF act via different mechanisms in rat isolated mesenteric arteries
1997
Myocardial ischemia-reperfusion injury: a neglected therapeutic target
2013 Standout
Transient receptor potential channels: targeting pain at the source
2008 StandoutNobel
Increased Plasma Endothelin-1 in Pulmonary Hypertension: Marker or Mediator of Disease?
1991
Regional haemodynamic responses to the cannabinoid agonist, WIN 55212‐2, in conscious, normotensive rats, and in hypertensive, transgenic rats
2001
Review article: endocannabinoids and their receptors in the enteric nervous system
2005
Tissue-Specific Regulation of Microvascular Diameter: Opposite Functional Roles of Neuronal and Smooth Muscle Located Vanilloid Receptor-1
2008
Biochemistry and pharmacology of endovanilloids
2007
The endocannabinoid system and its therapeutic exploitation
2004
Vascular estrogen receptors and endothelium-derived nitric oxide production in the mouse aorta. Gender difference and effect of estrogen receptor gene disruption.
1997
Endocannabinoids as cardiovascular modulators
2000
Anandamide and methanandamide induce both vanilloid VR1- and cannabinoid CB1 receptor-mediated changes in heart rate and blood pressure in anaesthetized rats
2001
Cannabinoid agonists induce contractile responses through Gi/o-dependent activation of phospholipase C in the bovine ciliary muscle
2004
Cannabinoid receptor homo- and heterodimerization
2005
The actions of the cannabinoid receptor antagonist, SR 141716A, in the rat isolated mesenteric artery
1998
Evidence of a novel site mediating anandamide‐induced negative inotropic and coronary vasodilatator responses in rat isolated hearts
2002
Haemodynamic profile and responsiveness to anandamide of TRPV1 receptor knock‐out mice
2004
Acute Renal Failure
1996 Standout
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
2006 Standout
‘Endocannabinoids’ and other fatty acid derivatives with cannabimimetic properties: biochemistry and possible physiopathological relevance
1998
Characterization of the mouse cold‐menthol receptor TRPM8 and vanilloid receptor type‐1 VR1 using a fluorometric imaging plate reader (FLIPR) assay
2004
TRP channels as cellular sensors
2003 StandoutNature
Involvement of CB1-receptors and β-adrenoceptors in the regional hemodynamic responses to lipopolysaccharide infusion in conscious rats
2004
Cellular signal transduction by anandamide and 2-arachidonoylglycerol
2000
UCM707, a potent and selective inhibitor of endocannabinoid uptake, potentiates hypokinetic and antinociceptive effects of anandamide
2002
Glial and neuronal control of brain blood flow
2010 StandoutNature
Cannabinoid CB1 receptors fail to cause relaxation, but couple via Gi/Go to the inhibition of adenylyl cyclase in carotid artery smooth muscle
1999
Interaction of Cardiovascular Risk Factors with Myocardial Ischemia/Reperfusion Injury, Preconditioning, and Postconditioning
2007
EDHF: bringing the concepts together
2002
Studies on the effects of anandamide in rat hepatic artery
1997
Neurobehavioral activity in mice of N-vanillyl-arachidonyl-amide
2000
The endogenous cannabinoid system and the basal ganglia
2002
The endocannabinoid system: function in survival of the embryo, the newborn and the neuron
2002
Detection of an Endogenous Cannabimimetic Molecule, 2-Arachidonoylglycerol, and Cannabinoid CB1 Receptor mRNA in Human Vascular Cells: Is 2-Arachidonoylglycerol a Possible Vasomodulator?
1998
The diverse CB1and CB2receptor pharmacology of three plant cannabinoids: Δ9‐tetrahydrocannabinol, cannabidiol and Δ9‐tetrahydrocannabivarin
2007 Standout
Structural snapshots of TRPV1 reveal mechanism of polymodal functionality
2021 StandoutNobel
The human eye expresses high levels of CB1 cannabinoid receptor mRNA and protein
2000
Production and physiological actions of anandamide in the vasculature of the rat kidney.
1997
Phosphorylation and Desensitization of Human Endothelin A and B Receptors
1997 StandoutNobel
Basic fibroblast growth factor in patients with intermittent claudication: results of a phase I trial
2000
Promotion of airway anastomotic microvascular regeneration and alleviation of airway ischemia by deferoxamine nanoparticles
2013 StandoutNobel
Anandamide and arachidonic acid use epoxyeicosatrienoic acids to activate TRPV4 channels
2003 Nature
Differential CB1 and CB2 cannabinoid receptor-inotropic response of rat isolated atria: Endogenous signal transduction pathways
2005
Analysis of effects of connexin-mimetic peptides in rat mesenteric small arteries
2006
THE ENDOCANNABINOID SYSTEM: PHYSIOLOGY AND PHARMACOLOGY
2004
Blockade of Effects of Smoked Marijuana by the CB1-Selective Cannabinoid Receptor Antagonist SR141716
2001
Cannabinoid CB1 receptor blockade enhances the protective effect of melanocortins in hemorrhagic shock in the rat
2002
Noxious Cold Ion Channel TRPA1 Is Activated by Pungent Compounds and Bradykinin
2004 StandoutNobel
Expression of Endothelin-1 in the Lungs of Patients with Pulmonary Hypertension
1993 Standout
Cannabinoid inhibition of the capsaicin‐induced calcium response in rat dorsal root ganglion neurones
2001
Vasodilator actions of abnormal‐cannabidiol in rat isolated small mesenteric artery
2003
Cannabinoid receptors and their ligands
2002
Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review
2007 Standout
Effects of creatine supplementation on body composition, strength, and sprint performance
1998
High-throughput random mutagenesis screen reveals TRPM8 residues specifically required for activation by menthol
2006 StandoutNobel
Targeted and natural (piebald-lethal) mutations of endothelin-B receptor gene produce megacolon associated with spotted coat color in mice
1994 Standout
Acute Renal Cortical Necrosis—A Study of 113 Patients
1994
Mustard oils and cannabinoids excite sensory nerve fibres through the TRP channel ANKTM1
2004 StandoutNatureNobel
Increased anandamide induced relaxation in mesenteric arteries of cirrhotic rats: role of cannabinoid and vanilloid receptors
2005
The Biosynthesis, Fate and Pharmacological Properties of Endocannabinoids
2005
The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
1992 Standout
Cannabinoids attenuate norepinephrine‐induced melatonin biosynthesis in the rat pineal gland by reducing arylalkylamine N‐acetyltransferase activity without involvement of cannabinoid receptors
2006
Trpv1 Reporter Mice Reveal Highly Restricted Brain Distribution and Functional Expression in Arteriolar Smooth Muscle Cells
2011 StandoutNobel
Anandamide transport inhibition by the vanilloid agonist olvanil
1999
Phosphorylation-Dependent Desensitization by Anandamide of Vanilloid Receptor-1 (TRPV1) Function in Rat Skeletal Muscle Arterioles and in Chinese Hamster Ovary Cells Expressing TRPV1
2005
Transient Receptor Potential Cation Channels in Disease
2007 Standout
Pulsatile Stretch and Shear Stress: Physical Stimuli Determining the Production of Endothelium-Derived Relaxing Factors
1998
The endocannabinoid signalling system: Biochemical aspects
2005
Isotope dilution GC/MS determination of anandamide and other fatty acylethanolamides in rat blood plasma
1998
Synergistic and additive interactions of the cannabinoid agonist CP55,940 with μ opioid receptor and α2‐adrenoceptor agonists in acute pain models in mice
2005
The Super-Cooling Agent Icilin Reveals a Mechanism of Coincidence Detection by a Temperature-Sensitive TRP Channel
2004 StandoutNobel
Cannabinoid receptors in atherosclerosis
2006
Atypical cannabinoid stimulates endothelial cell migration via a Gi/Go-coupled receptor distinct from CB1, CB2 or EDG-1
2004
Evidence for novel cannabinoid receptors
2005
TRPV1 Channels Mediate Long-Term Depression at Synapses on Hippocampal Interneurons
2008
Endocannabinoids and the gut
2002
Central and peripheral components of the pressor effect of anandamide in urethane‐anaesthetized rats
2005
TRPV3 regulates nitric oxide synthase-independent nitric oxide synthesis in the skin
2011 StandoutNobel
Antibodies to von Willebrand Factor–Cleaving Protease in Acute Thrombotic Thrombocytopenic Purpura
1998 Standout
TRPV1 and TRPA1 Mediate Peripheral Nitric Oxide-Induced Nociception in Mice
2009 StandoutNobel
Cannabinoid and cannabinoid‐like receptors in microglia, astrocytes, and astrocytomas
2010
Anandamide‐induced mobilization of cytosolic Ca2+ in endothelial cells
1999
The quest for a vascular endothelial cannabinoid receptor
2002
Cannabinoid receptor CB1 mRNA is highly expressed in the rat ciliary body: implications for the antiglaucoma properties of marihuana
1998
Marijuana in the management of amyotrophic lateral sclerosis
2001
Effects of thrombosis on vascular tone in rat mesenteric arteries with endothelium in vivo.
1990
CANNABINOID RECEPTORS AND THEIR ENDOGENOUS AGONISTS
1998
Platelets and shear stress
1996
Unresponsiveness to Cannabinoids and Reduced Addictive Effects of Opiates in CB 1 Receptor Knockout Mice
1999 StandoutScience
N-arachidonylethanolamide relaxation of bovine coronary artery is not mediated by CB1 cannabinoid receptor
1998
ACC/AHA 2005 Practice Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic)
2006 Standout
Systemic and portal hemodynamic effects of anandamide
2001
Endocannabinoids and liver disease† ‡
2005
Is there a role for anandamide in cardiovascular regulation? Insights from studies of endocannabinoid metabolism
2005
Cardiovascular and renal control in NOS-deficient mouse models
2003
Exogenous Anandamide Protects Rat Brain against Acute Neuronal InjuryIn Vivo
2001
Incorporation of therapeutically modified bacteria into gut microbiota inhibits obesity
2014
Cannabinoid CB1 receptor of cat cerebral arterial muscle functions to inhibit L-type Ca2+channel current
1999
An endothelium-derived hyperpolarizing factor distinct from NO and prostacyclin is a major endothelium-dependent vasodilator in resistance vessels of wild-type and endothelial NO synthase knockout mice
2000
Mesenteric Vasodilation Mediated by Endothelial Anandamide Receptors
1999
Endothelium‐dependent hyperpolarizations: Past beliefs and present facts
2007
Putative mechanism of hypotensive action of platelet-activating factor in dogs.
1992 StandoutNobel
G Protein-Coupled Receptors: Functional and Mechanistic Insights Through Altered Gene Expression
1998 StandoutNobel
Platelet‐ and macrophage‐derived endogenous cannabinoids are involved in endotoxin‐induced hypotension
1998
A FAAH-Regulated Class of N-Acyl Taurines That Activates TRP Ion Channels
2006 StandoutNobel
TRPV4 calcium entry channel: a paradigm for gating diversity
2004
Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors
1999
Neuroprotective Effects of Creatine and Cyclocreatine in Animal Models of Huntington’s Disease
1998
Cannabinoids and Neuroprotection in Global and Focal Cerebral Ischemia and in Neuronal Cultures
1999
Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old Drugs
2005 Standout
VR1-Mediated Depressor Effects During High-Salt Intake
2005
Endocannabinoids and Neuroprotection
2002
The Vanilloid Receptor: A Molecular Gateway to the Pain Pathway
2001 StandoutNobel
TRP ION CHANNELS AND TEMPERATURE SENSATION
2006 StandoutNobel
Particulate Matter Air Pollution and Cardiovascular Disease
2010 Standout
P-450 Metabolites of Arachidonic Acid in the Control of Cardiovascular Function
2002
The gap junction cellular internet: connexin hemichannels enter the signalling limelight
2006
CANNABINOID RECEPTORS AS THERAPEUTIC TARGETS
2005
Emerging Targets in Photopharmacology
2016 StandoutNobel
Anandamide-induced vasorelaxation in rabbit aortic rings has two components: G protein dependent and independent
2002
Vascular targets for cannabinoids: animal and human studies
2013
Plant, Synthetic, and Endogenous Cannabinoids in Medicine
2005
N-arachidonoyll -serine, an endocannabinoid-like brain constituent with vasodilatory properties
2006
Endocannabinoids and Vascular Function
2000
Hydrogen sulfide-induced relaxation of resistance mesenteric artery beds of rats
2004
Creatine and Creatinine Metabolism
2000 Standout
Anandamide-Induced Depressor Effect in Spontaneously Hypertensive Rats
2003
Physiology of Microglia
2011 Standout
Endothelial Function and Dysfunction
2007 Standout
Works of Michael D. Randall being referenced
Endocannabinoids: a new class of vasoactive substances
1998
‘Entourage’ effects of N‐palmitoylethanolamide and N‐oleoylethanolamide on vasorelaxation to anandamide occur through TRPV1 receptors
2008
Anandamide and endothelium-derived hyperpolarizing factor act via a common vasorelaxant mechanism in rat mesentery
1998
Collateral Perfusion: The Role of Endothelium-Derived Relaxing Factor and Effects of Vasodilators
1992
Vanilloid receptors on capsaicin‐sensitive sensory nerves mediate relaxation to methanandamide in the rat isolated mesenteric arterial bed and small mesenteric arteries
2000
The endothelial component of cannabinoid‐induced relaxation in rabbit mesenteric artery depends on gap junctional communication
1999
Characterization of cannabinoid receptors coupled to vasorelaxation by endothelium-derived hyperpolarizing factor
1999
Characterisation of the vasorelaxant properties of the novel endocannabinoid N‐arachidonoyl‐dopamine (NADA)
2004
The role of gap junctions in mediating endothelium‐dependent responses to bradykinin in myometrial small arteries isolated from pregnant women
2002
The complexities of the cardiovascular actions of cannabinoids
2004
Comparative pharmacology of endothelium-derived hyperpolarizing factor and anandamide in rat isolated mesentery
1997
Characterization and modulation of EDHF‐mediated relaxations in the rat isolated superior mesenteric arterial bed
1997
Time-dependent vascular actions of cannabidiol in the rat aorta
2009
Effects of hypertension on vasorelaxation to endocannabinoids in vitro
2008
Heterogeneity in the mechanisms of vasorelaxation to anandamide in resistance and conduit rat mesenteric arteries
2004
Pressor Effects of Endothelin-1 and Some Analogs in the Perfused Superior Mesenteric Arterial Bed of the Rat
1989
Involvement of a cannabinoid in endothelium-derived hyperpolarizing factor-mediated coronary vasorelaxation
1997
Cardiovascular effects of cannabinoids
2002
Effects of chronic nitric oxide synthase inhibition on the cardiovascular responses to cannabinoids in vivo and in vitro
2007
The effects of Δ9‐tetrahydrocannabinol in rat mesenteric vasculature, and its interactions with the endocannabinoid anandamide
2005
Enhanced vasorelaxant effects of the endocannabinoid-like mediator, oleamide, in hypertension
2012
Characterization of vasorelaxant responses to anandamide in the rat mesenteric arterial bed
2002
Vascular activities of endothelin‐1 and some alanyl substituted analogues in resistance beds of the rat
1989
Vascular effects of Δ9-tetrahydrocannabinol (THC), anandamide and N-arachidonoyldopamine (NADA) in the rat isolated aorta
2005
Differential effects ofl ‐arginine on the inhibition by NG‐nitro‐l ‐arginine methyl ester of basal and agonist‐stimulated EDRF activity
1991
Enhanced cardiac preconditioning in the isolated heart of the transgenic ((mREN-2)27) hypertensive rat
1997
An Endogenous Cannabinoid as an Endothelium-Derived Vasorelaxant
1996
Role of gap junctions in endothelium-derived hyperpolarizing factor responses and mechanisms of K+-relaxation
2000
Sex differences in the relative contributions of nitric oxide and EDHF to agonist‐stimulated endothelium‐dependent relaxations in the rat isolated mesenteric arterial bed
1998
Effects of moderate hypoxia, hypercapnia and acidosis on haemodynamic changes induced by endothelin‐1 in the pithed rat
1989
COMMENTARY Endothelins: from laboratory to clinic?
1994
Attenuation by creatine of myocardial metabolic stress in Brattleboro rats caused by chronic inhibition of nitric oxide synthase
1995
Cannabinoid modulation of sensory neurotransmission via cannabinoid and vanilloid receptors: Roles in regulation of cardiovascular function
2002
Differential effects of endotoxaemia on pressor and vasoconstrictor actions of angiotensin II and arginine vasopressin in conscious rats
1998
Time‐Dependent Vascular Effects of Endocannabinoids Mediated by Peroxisome Proliferator‐Activated Receptor Gamma (PPARγ)
2009
Detergent and methylene blue affect endothelium‐dependent vasorelaxation and pressure/flow relations in rat blood perfused mesenteric arterial bed
1988
Differential mechanisms of endothelium-dependent vasodilator responses in human myometrial small arteries in normal pregnancy and pre-eclampsia
2002
EDRF plays central role in collateral flow after arterial occlusion in rabbit ear
1992
Further Characterization of the Time-Dependent Vascular Effects of Δ9-Tetrahydrocannabinol
2006
The in Vitro and in Vivo Cardiovascular Effects of Δ9-Tetrahydrocannabinol in Rats Made Hypertensive by Chronic Inhibition of Nitric-Oxide Synthase
2007
Novel time-dependent vascular actions of Δ9-tetrahydrocannabinol mediated by peroxisome proliferator-activated receptor gamma
2005